Wang S J, Cheng L L, Gean P W
Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan City, Taiwan 701.
J Neurosci. 1999 Jan 15;19(2):570-7. doi: 10.1523/JNEUROSCI.19-02-00570.1999.
Neurotransmitter receptors are often colocalized in a neuron with other receptors, and activation of one receptor can either amplify or antagonize the response to a colocalized receptor. The aim of this study was to investigate the cross-regulation of synaptic transmission by beta-adrenergic and serotonin 1A (5-HT1A) receptors and to elucidate their underlying mechanisms. Stimulation of presynaptic beta-adrenergic receptors with isoproterenol (Iso) in the basolateral amygdala resulted in a long-lasting increase in synaptic transmission. This effect was mimicked by forskolin, an activator for adenylyl cyclase and a cAMP analog. In addition, the effect of forskolin was blocked by catalytic and regulatory site antagonists for cAMP-dependent protein kinase (PKA), indicating a PKA-mediated mechanism. Application of 5-HT depressed the synaptic transmission and blocked Iso- and forskolin-induced potentiation. The effect of 5-HT was mimicked by the selective 5-HT1A agonist 8-hydroxy-dipropylaminotetralin and was blocked by the selective 5-HT1A antagonist 1-(2-methoxyphenyl)-4[4-(2-phthalimido)butyl]piperazine, indicating its mediation by 5-HT1A receptors. To determine the locus of interaction, Sp-cAMPS, a membrane-permeable activator of PKA, was applied, and the potentiation produced by Sp-cAMPS was completely blocked in slices pretreated with 5-HT. These results suggest that the interaction between the intracellular signaling pathways activated by 5-HT1A and beta-adrenergic receptors occurs at a step downstream from cAMP production.
神经递质受体通常与其他受体共定位在一个神经元中,一种受体的激活可以增强或拮抗对共定位受体的反应。本研究的目的是研究β-肾上腺素能受体和5-羟色胺1A(5-HT1A)受体对突触传递的交叉调节作用,并阐明其潜在机制。在基底外侧杏仁核中用异丙肾上腺素(Iso)刺激突触前β-肾上腺素能受体,导致突触传递的持久增加。这种效应被毛喉素(一种腺苷酸环化酶激活剂和一种cAMP类似物)模拟。此外,毛喉素的效应被cAMP依赖性蛋白激酶(PKA)的催化和调节位点拮抗剂阻断,表明这是一种PKA介导的机制。应用5-羟色胺可抑制突触传递,并阻断Iso和毛喉素诱导的增强作用。5-羟色胺的效应被选择性5-HT1A激动剂8-羟基-二丙基氨基四氢萘模拟,并被选择性5-HT1A拮抗剂1-(2-甲氧基苯基)-4-[4-(2-邻苯二甲酰亚胺基)丁基]哌嗪阻断,表明其由5-HT1A受体介导。为了确定相互作用的位点,应用了Sp-cAMPS(一种PKA的膜通透性激活剂),在用5-羟色胺预处理的切片中,Sp-cAMPS产生的增强作用被完全阻断。这些结果表明,5-HT1A和β-肾上腺素能受体激活的细胞内信号通路之间的相互作用发生在cAMP产生的下游步骤。